All News

Focal laser ablation is safe and can be performed without the troubling complications associated with more aggressive therapies for low-risk prostate cancer, results of a small phase I study indicate.

More stringent criteria may be needed for African-American men with prostate cancer when considering active surveillance for their disease, new research from The Cancer Institute of New Jersey, New Brunswick suggests.

Patients with high-risk prostate cancer who undergo 18 months of androgen blockade live as long as those who have 36 months of treatment, according to results of a recent phase III study.

Placement of an inflatable penile prosthesis (IPP) approximately 3 months after T-shunt surgery in men with acute ischemic priapism and refractory erectile dysfunction is associated with favorable outcomes at 1 year, according to data from a small series of such patients.

Use of tivozanib, an experimental tyrosine kinase inhibitor (TKI) with increased specificity and potency for the vascular endothelial growth factor (VEGF) receptor, as initial targeted therapy for patients with advanced renal cell carcinoma did not translate into improved overall survival compared with sorafenib (Nexavar) in a phase III clinical trial.

A recent study highlights huge price swings in patient charges for the 10 most common outpatient conditions-including kidney stones and urinary tract infection-in emergency rooms across the country.

The AUA is participating in a recently launched ad campaign urging Congress to fight cuts to federal funding for graduate medical education.

Nearly three-quarters of patients undergoing radiation therapy for prostate cancer had no evidence of the disease at 25 years’ follow-up, the authors of a study from Radiotherapy Clinics of Georgia, Atlanta recently reported.

The AUA has released a new white paper providing recommendations for optimal prostate biopsy sampling, labeling, and processing.

For women with uncomplicated, stress-predominant incontinence, urodynamic testing adds considerable expense without improving surgical outcomes, a recent trial shows.

OnabotulinumtoxinA (Botox) has earned FDA approval for the treatment of overactive bladder in adults who cannot use or don't adequately respond to anticholinergic drugs, and its potential uses in urology may not end there.

Publication of the Value of Urodynamic Evaluation study has drawn attention to whether urodynamics improves patient outcomes when added to an office evaluation of stress urinary incontinence before surgical intervention.

Preoperative urodynamic testing in women undergoing surgery for uncomplicated, stress-predominant urinary incontinence commonly results in a change in clinical diagnosis.

Drugs and devices in the pipeline from Bayer Healthcare, AVEO Oncology, Astellas Pharma Inc., Trimel Pharmaceuticals Corp., OncoGenex Pharmaceuticals, Inc., Nymox Pharmaceutical Corp., Spectrum Pharmaceuticals, and Tengion, Inc.

Recent analyses of urodynamic testing data indicate that both autologous fascial pubovaginal sling and synthetic midurethral sling procedures decrease maximum flow rate and increase bladder outlet resistance, but the pubovaginal sling was found to create more bladder outlet resistance.

The incidence of secondary malignancies following prostate cancer therapy is similarly uncommon whether the treatment is surgery, brachytherapy, or external beam therapy.

The tax laws have changed once again. Find out how they're going to affect you.

Advanced age does not influence postoperative continence or cancer-specific survival after radical prostatectomy, according to a recent study.

Urologists share how confident they feel about active surveillance for low-risk prostate cancer.

To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.

Wondering how to keep your appointment book full? Discover how marketing can help your practice.

One in five U.S. physicians are over 65 years of age as of 2010, the American Medical Association reports. Some experts say that regular cognitive and physical screenings are needed once physicians reach 65 or 70 years of age, but no standardized screening is available. Age, of course, is not always a negative factor, says urologist Sivaprasad D. Madduri, MD.

Sequester cuts could endanger the medical work force, as well as access to care.

The AUA has released a list of specific tests or procedures that are commonly ordered but not always necessary in urology.

A new study suggests that exercise may reduce Caucasian men's risk of developing prostate cancer.

Many synthetic chemicals, untested for their disrupting effects on the hormone system, may have significant health implications, including contributing to the development of prostate cancer in men and undescended testes in young males.

New York’s Integrated Medical Professionals, PLLC and Weill Cornell Medical College have appointed urologists to new posts.

Three "field effect" epigenetic biomarkers were found to be more prevalent in histologically benign biopsy cores from prostate cancer patients diagnosed with Gleason score 7 prostate cancer than in those with low-volume Gleason 6 disease, researchers reported at the Genitourinary Cancers Symposium in Orlando, FL.